Members and Affiliations
| A B C D E F G H J K L M N O P Q R S T V W Z | |||
| Name | Affiliation | Specialty | Details |
| Lorel Adams BSc, MN |
Macquarie University ASAM | Epidemiology and Biobanking | More |
| Ammar Al-Chalabi, MB, PhD, MRCP, ChD, FRCP |
King's College London | Genetic and other risk factors for sporadic ALS | More |
| Steven Albert, PhD, MSPH |
University of Pittsburgh Behavioral and Community Health Sciences | Environmental and Occupational Exposures | More |
| Kelli Dominick Allen, PhD |
Center for Health Sciences Research in Primary Care | ALS exposures | More |
| Ahmed Arif, PhD, MS |
University of North Carolina Department of Public Health Sciences | Environmental, occupational, and life style factors in ALS | More |
| Carmel Armon, MD
|
Tufts University School of Medicine | Neuroepidemiology | More |
| William Aschenbach, PhD |
Biogen Idec, Weston, MA | World- wide ALS registry | More |
| Alberto Ascherio, MD |
Harvard School of Public Health | Nutrition | More |
| Ettore Beghi, MD |
University of Milano | Neuroepidemiology | More |
| Michael Benatar , MD, MS, PhD |
Emory University | Familial ALS | More |
| Amy Borenstein , PhD |
University of South Florida | Neuroepidemiology of ALS | More |
| Daryl Bosco , PhD |
University of Massachusetts Medical School | To identify factors involved in sporadic ALS | More |
| Jeannie Boyle, BSN |
University of New Mexico | Research development, epidemiologic factors in ALS | More |
| Walter Bradley, DM, FRCP |
Miller School of Medicine, University of Miami | Etiology and epidemiology of ALS, especially the cyanobacterial BMAA hypothesis | More |
| Christopher Brady, PhD |
VA Boston Healthcare Center | Neuropsychology, ALS Brain Bank | More |
| Marlia Braun, PhD, RD |
UC Davis | Nutrition, quality of life and ALS | More |
| Benjamin Rix Brooks, MD |
Carolinas ALS Center | Neurology, population health science, National ALS Registry | More |
| Robert H. Brown Jr, MD, DPhil |
Harvard Medical School | Biology of neuromuscular disease | More |
| Lucie Bruijn, PhD
|
ALS Association | Any avenue of relevance to ALS | More |
| Miriam Bucheli, PhD
|
Universidad San Francisco de Quito | Gene Expression, ALS registry, Neurodegeneration | More |
| Tracie Caller, MD, MPH |
Dartmouth-Hitchcock Medical Center | Environmental links and clustering of ALS | More |
| Grace Carlson-Lund, RN, BSN |
Northwestern University | Environmental risk factors for ALS and PLS | More |
| Carla Cerra, MSN |
Hennepin County Medical Center | Needs of personal caregivers of patients with ALS | More |
| María Chávez |
Universidad Francisco Marroquín | Genetics, Molecules that might slow ALS | More |
| Honglei Chen, MD, MSc, PhD |
Epidemiology Branch NIEHS | Environmental and genetic risk factors | More |
| Adriano Chiò, MD |
University of Turin | Physical activity risk factors | More |
| Jay Christian, MPH, PhD |
University of Kentucky | Epidemiology | More |
| Robin Conwit, MD |
NIH/NINDS | Clinical Neurophysiology | More |
| Philippe Couratier, MD, PhD |
Limoges University Hospital | Pronostic factors in ALS | More |
| Merit Cudkowicz, MD, MSc |
Harvard University | Transgenic ALS models | More |
| John Dement, PhD |
Duke University | Occupational risks for ALS | More |
| Brian Dickie, PhD |
MND Association, UK | Mechanisms of Motor Neuron Degeneration | More |
| Dubravka Dodig, MD |
Montreal Neurological Institute and Hospital | ALS Clinical Epidemiology | More |
| Renee Douville, PhD |
University of Winnipeg | Expression of human endogenous retroviruses (HERV) in ALS | More |
| Nicolas Dupré, MD |
Université Laval | Epidemiology and genetics of ALS | More |
| Arthur Ersner, MD |
Montgomery Medical Center | ALS comprehensive epidemiologic database | More |
| Nicholas Field , BA |
Dartmouth-Hitchcock Medical Center | Epidemiology of ALS, specifically a potential association with cyanobacteria | More |
| Cecilia Figueiredo, MSc |
Universidade de Fortaleza | Epidemiology of ALS | More |
| Jordan Firestone , MD, MPH |
University of Washington Occupational and Environmental Medicine Clinic | Environmental risk factors | More |
| Dallas Forshew, RN, BSN |
UC San Francisco ALS Center | Research project planning and Development | More |
| Kevin Francis, BS |
Trinity Partners | Engagement Manager | More |
| Jan Frich, MD, PhD, MSc |
Oslo University Hospital, Rikshospitalet | Health Service Research | More |
| Deborah Gelinas , BSc, MD |
Michigan State University | Causation, Diagnosis, and Treatment of ALS | More |
| Angela Genge , MD, FRCP |
McGill University | ALS clinical risk factors | More |
| Diane Goostree, CEO |
BioPharma Catalyst Group | Venture capital stage pharmaceutical development | More |
| Paul Gordon, MD |
Columbia University | ALS clinical research | More |
| Kimberly Gray, PhD |
NIEHS | Short and long-term health effects of environmental exposures on neuronal processes | More |
| Patrick Gray, PhD |
Omeros Corporation | Animal models, drug testing, clinical trials | More |
Giles Guillemin, PhD |
Macquarie University | Tryptophan metabolism | More |
| Daikwon Han, PhD |
Texas A&M Health Science Center | GIS, Environmental Epidemiology | More |
| Vahid Harandi, MSc |
Umeå University | Identify early changes of neutroptophic factors in ALS | More |
| Yadollah Harati, MD |
Baylor College of Medicine | Epidemiology of ALS | More |
| Orla Hardiman, MD, FRCPI, BSc, FAAN |
Royal College of Surgeons in Ireland | Incidence and prevalence of ALS | More |
| Matthew Harms, MD |
Washington University School of Medicine | Genomics of ALS | More |
| Ann Haugh |
California Pacific Medical Center | Cliinical | More |
| D.J.J. (Dick) Heederik,MSc, PhD |
Utrecht University The Netherlands |
Environmental risk factors | More |
| Khosrow Heidari, MA, MSMSc, MSS |
South Carolina Department of Health and Environmental Control | Surveillance, community impact | More |
| Terry Heiman-Patterson, MD |
Drexel University College of Medicine Department of Neurology | Areas of increased incidence, risk factors by geographic location | More |
| Patricia Henegan, BS |
Dartmouth - Hitchcock Medical Center | Spatial analysis and environmental risk factors of ALS | More |
| Elena Herrero Hernández, MD, PhD |
Universitat Rovira i Virgili | Occupational and environmental risk factors | More |
| Ronnie Horner, PhD |
University of Cincinnati | Natural history of neurologic disorders | More |
| Howard Hu, MD |
University of Michigan | Occupational/environmental medicine | More |
| Julian Jaeger |
University College London | Genetics of ALS | More |
| Sheng Jinghao, PhD |
Zhejiang University, School of Medicine | Pathogenesis of ALS | More |
| Freya Kamel, PhD |
NIH/NIEHS | Environmental determinants of neurologic dysfunction | More |
| Edward Kasarskis, MD, PhD |
University of Kentucky | Toxicology, genetics and nutrition | More |
| Wendy Kaye, PhD |
McKing Consulting Corp | Surveillance for immunological and neurological diseases | More |
| Carlos Ketzoian, Ord.Doc |
Universidad de la República | Neurology and Epidemiology of motor neuron disease | More |
| Jane Koenig, PhD |
City of Hope | Bench neuroscience, synaptic transmission | More |
| Laura Koetter, MS |
Seimens Healthcare | Lifestyle and environmental determinants of ALS | More |
| Svetlana Kostic, MD |
Clinical Centre Zvezdara | Epidemiology of motor neuron disease | More |
| Kyle Kuhn |
Acorda Therapeutics | Drug Development | More |
| Jason Kwan, BSc |
University of Toronto | Biotechonolgy | More |
| Arlene LaFaire, MSW |
ALS Association Saint Louis, Missouri | Patient services | More |
| Nigel Leigh, MD, PhD, FRCP |
University of London MND Center | Clinical neuroscience | More |
| Maurizio Leone, MD |
Universita A. Avogadro | Neuropidemiology | More |
| Marc Levinson, PhD |
Cobden, Il | Clinical Psychologist | More |
| Gleb Levitsky, PhD |
Russian State Medical University | Electromyography | More |
| Jin Billy Li, BS, MS, PhD |
Stanford University | RNA editing alteration in ALS | More |
| Ko-Hong Lin, BS |
Taipei Medical University | Clinical Pharmacogenomics | More |
| Giancarlo Logroscino, MD, PhD |
Harvard University | Genetic epidemiology | More |
| Catherine Lomen-Hoerth , MD, PhD |
UC San Francisco ALS Center | Electro physical and genetic predictors | More |
| Sheng Luo , PhD |
University of Texas at Houston Health Center | Statistical methods in studying ALS | More |
| Suneil Malik, PhD |
Public Health Agency of Canada | Epidemiology of neurodegenerative disease | More |
| Benôt Marin, MD, PhD |
Limoges University | ALS Epigemiology, biomarkers | More |
| Valerie McGuire, PhD |
Stanford University | Risk factors and instrument design | More |
| Diane McKenna-Yasek, BSN |
Massachusetts General Hospital | Genetics and environmental risk factors | More |
| Matthew Miller, PhD |
McMaster Immunology Research Center | Relationship between infection-inflammation-neurodegeneration | More |
| Robert Miller, MD |
California Pacific Medical Center | Clinical trials | More |
| Timothy M Miller, MD |
University of Arizona Health Sciences Center | Neurology | More |
| Douglas Mitchell, MD, FRCP |
Preston MND Care & Research Centre | All aspects of motor neurone diseases including ALS | More |
| Hiroshi Mitsumoto, MD, DSc |
Columbia University | Genetic environmental epidemiology in ALS | More |
| Jesus Mora, MD, BC |
Instituto de Salud Carlos III | Clinical trials and epidemiology of ALS | More |
| Nalini Narotam, MSc |
Walden University | Epidemiology of ALS | More |
| Lorene Nelson, PhD |
Stanford University | Epidemiologic accessment instruments, genetics | More |
| Joyce Nicholas, PhD |
Medical University of South Carolina | Epidemiology and biostatistics | More |
| Eugene Oddone, MD, MHSc |
Duke University | Clinical trials | More |
| Maryam Oskoui, MD |
McGill University | Epidemiology and clinical trials | More |
| Ruth Ottman, PhD |
Columbia University | Genetic epidemiology of ALS | More |
| Roger Pamphlett, MB, ChB, MD |
University of Sydney | Gene environment interactions | More |
| Jane Parkin Kullmann, MS |
University of Sydney | Environmental toxins and gene environment interactions | More |
| Susan Paulukonis, MA, MPH |
California Rare Disease Surveillance | ALS Surveillance | More |
| Steven Perrin, PhD |
ALS Therapy Development Institute | Identification of biomarkers | More |
| Maria Skaalum Petersen, PhD |
The Faroese Hospital System | Epidemiology, gene environment interactions | More |
| Rita Popat, PhD |
Stanford University | Epidemiology | More |
| Ashley Pratt, BA |
Scripps Research Institute | Molecular Biology | More |
| M. Muddasir Qureshi, MD |
Massachusetts General Hospital | Clinical neuroepidemiology | More |
| Evadnie Rampersaud, MD |
University of Miami Miller School of Medicine | Genetics of ALS | More |
| Stephen Renner, MD |
Southern Arizona VA Health Care System | Pathology, biorepository | More |
| J Steven Reznick, BA. MA, PhD |
University of North Carolina | Causes of ALS, varieties of ALS progression, possible treatments | More |
| Andrea Rosso, MPH |
Drexel University College of Medicine | Neurology, epidemiology and biostatistics | More |
| Dominic Rowe, MBBS PhD |
Macquarie University | Epidemiology of sporatic ALS | More |
| Dawn Rowe-Morling, BS MBA |
Personal | Epidemiology of ALS | More |
| Dipak Roy, MSc |
Center for Cellular & Molecular Biology | Brain energy metabolism in ALS | More |
| Stacy Rudnicki, MD |
University of Arkansas for Medical Sciences | Risk factors for ALS | More |
| Rebeccah Rush |
ALS Worldwide | Studies of ALS Clusters | More |
| Dikaios Sakellariou, MSc |
Cardiff University | Clinical care in ALS | More |
| Jill Schinkel, MS |
America's Health Insurance Plans | Epidemiology of ALS | More |
| Silke Schmidt, PhD |
Duke University | Genetic epidemiology of ALS | More |
| William Scott, PhD |
University of Miami | Gene-environment interactions in neurodegenerative diseases | More |
| Jinghao Sheng, PhD |
Zhejiang University, School of Medicine | Pathogenesis of ALS | More |
| Sara Shnider , PhD |
Prize4Life | ALS Forum Web Site | More |
| Christen Shoesmith , MD, FRCPC |
University of Western Ontario | Epidemiology, clinical neurology | More |
| Zohar Shtalryd , MD, |
Israeli Center for Disease Control | Epidemiology, ALS registry | More |
| Nailah Siddique, RN, MSN |
Northwestern University | Clinical nursing, ALS genetics | More |
| Teepu Siddique, MD |
Northwestern University | Molecular basis of neurodegeneration | More |
| Zoltan Simandi, PhD |
Sanford Burnham Prebys Medical Discovery | Bench neuroscience, genetics | More |
| Saira Singh, BA, MBA |
Valent Technologies R&D | Ion channel inhibitors as therapeutics | More |
| Veronica Skvortsova, PhD |
Russian State Medical Center | Genetics | More |
| Lenka Slachtova, PhD |
Charles University 1st Medical School | Genetic epidemiology of ALS | More |
| Andrew Smirnov |
Russian State Medical University | Neurology | More |
| Maria Giuliana Solinas, PhD |
University of Sassari | Genetic and environmental risks | More |
| You-Qaing Song, MD |
The University of Hong Kong | Biochemistry, genomics | More |
| Peter Spencer, PhD, FRCPath |
Oregon Health and Science University | Gene environment interaction | More |
| Zorica Stevic, MD |
Institute of Neurology Belgrade | Clinical | More |
| David Stickler, MD |
Medical University of South Carolina | Integrated care for ALS patients | More |
| Dan Strickland, MSPH, PhD |
Southern California Permanente Medical Group | ALS Etiologic Studies | More |
| Michael Strong, MD, FRCPC |
University of Western Ontario | Pathogenesis of ALS | More |
| Enchtuja Suchegin, MD |
Landspitali University Hospital | Epidemiology of ALS | More |
| Robert Swingler, MD, FRCPE |
ALS/NMD Research Clinic, Ninewells Hospital | Epidemiology and genetics of NMD/ALS | More |
| Caroline Tanner, MD, PhD |
Parkinson's Institute | Environmental toxicology and epidemiology | More |
| Nimish Thakore, MD |
Cleveland Clinic | ALS Epidemiology | More |
| Rochelle Tractenberg, MPH, PhD |
Georgetown University | ALS Neuropathology | More |
| Bryan Traynor, MD, MRCPI |
NIMH Section on Developmental Genetic Epidemiology | Population genetics, care models | More |
| Leonard Van Den Berg, MD, PhD |
University Medical Center Utrecht | Neuromuscular disorders | More |
| Stephen Van Den Eeden, PhD |
Kaiser Division of Research | Neurogenetics, neuroepidemiology | More |
| John Vena, PhD |
University of South Carolina | Epidemiology and biostatistics | More |
| Ashok Verma, MD, DM, MBA |
University of Miami Miller School of Medicine | Clinically oriented ALS research | More |
| Mayank Verma, BS, MSTP Student |
University of Minnesota Medical School | ALS, DMD | More |
| Pratik Verma , PhD |
AgeTak Inc. | Health Care Informatics | More |
| Jean-Françios Viel , MD PhD |
Université de Rennes | Geographical patterns of health and disease | More |
| Subbiah Vivekanandhan, MSc, PhD |
All India Institute of Medical Sciences | Mitochondrial proteomics | More |
| Joshua Ward, PhD |
New England Primate Research Center | Increasing the translational efficacy of animal models for ALS. | More |
| Michael Warmoth, MD |
Spectrum Health | Infectious candidates which may trigger ALS | More |
| Marc Weisskopf, PhD, ScD |
Harvard University School of Public Health | Underlying processes and risk factors for neurodegenerative disease | More |
| Martina Wiedau-Pazos, MD |
UCLA Neurology | Gene expression studies and neurobiology | More |
| Lisa Williams, BSc |
Kings College London | Biobanking | More |
| Dhelia Williamson, PhD |
Centers for Disease Control and Prevention | Etiology of ALS | More |
| Anne-Marie Wills, MD |
Massachusetts General Hospital | Genetic/environmental interactions | More |
| Senait Woldai, BSc |
Georgia Southern University | ALS and its association with smoking and/or lifestyle | More |
| Christina Wolfson, BSc, MSc, PhD |
McGill University Health Centre | Clinical epidemiology and biostatistics | More |
| Zhenzhen Zheng |
Sichuan University | Neurology | More |
| Lixian Zhong, PhD |
UCSF Dept of Clinical Pharmacy | ALS Epidemiology, Health Economics | More |
| Qinsong Zhu, COO |
In Silico Medicine Inc | ALS Epidemiology, Drug development | More |
| Annelies Zittersteijn |
European Neuromuscular Centre | Research organization | More |
|
This document was last modified: Sunday, 27-Aug-2017 10:47:29 PDT |




